BackMagellan Health Overview

Magellan Health Net Income

Magellan Health's net income is $300M, below the Healthcare sector average of $16B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

$5.94M
↓ 49.03% YoY

As of Sep 2021

Annual Net Income (TTM)

$302.03M
↑ 125.42% YoY

Trailing 12 months ending Sep 2021

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Magellan Health (MGLN) FAQ

Magellan Health (MGLN) currently reports a net income of $300M as of September 2021. That compares with $130M in the prior-year period — up 125.4% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Magellan Health's net income history and peer comparisons.

Magellan Health's net income increased from $130M to $300M — a 125.4% year-over-year increase (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Magellan Health's net income of $300M is lower than the Healthcare sector average of $16B. That is roughly 98.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Magellan Health reported $300M in net income as of September 2021. That compares with $130M in the prior-year period — up 125.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $300M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Magellan Health, and consider following MGLN for alerts when major investors trade the stock.